Literature DB >> 20062014

Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma.

Alvaro P Pinto1, Alexander Miron, Yosuf Yassin, Nicolas Monte, Terri Y C Woo, Karishma K Mehra, Fabiola Medeiros, Christopher P Crum.   

Abstract

Differentiated vulvar intraepithelial neoplasia is a unique precursor to vulvar squamous cell carcinoma that is typically HPV-negative and frequently associated with nuclear p53 staining. These features imply a mode of pathogenesis involving somatic mutations. However, the genetic relationship of differentiated vulvar intraepithelial neoplasm and vulvar squamous cell carcinoma and the role of Tp53 mutations in this process have not been resolved. We analyzed 11 differentiated vulvar intraepithelial neoplasms and 6 associated vulvar squamous cell carcinomas. Sections were stained for p53 and p63 and DNA from multiple epithelial sites, representing normal control tissues (n=10), differentiated vulvar intraepithelial neoplasias (n=18), and vulvar squamous cell carcinomas (n=6), were obtained by laser capture microdissection, and sequenced for exons 2-11 of Tp53. Six of 10 cases contained at least one Tp53 mutation-positive differentiated vulvar intraepithelial neoplasia focus; 4 strongly p53 immuno-positive and 2 negative. Staining for p53 and p63 co-localized, targeting the immature epithelium, but surface epithelium was Tp53 mutation-positive. Four of five vulvar squamous cell carcinomas were Tp53 mutation-positive; two shared identical Tp53 mutation with adjacent differentiated vulvar intraepithelial neoplasia. Disparate foci of differentiated vulvar intraepithelial neoplasia often showed different mutations consistent with multiple neoplastic clones. Differentiated vulvar intraepithelial neoplasia is, with few exceptions, associated with Tp53 mutations and will be p53 immunopositive when missense mutations (versus some nonsense and all deletion mutations) are present. Multiple Tp53 mutations in different sites supports the presence of multiple independent genetic events, but shared Tp53 mutations in both differentiated vulvar intraepithelial neoplasia and vulvar squamous cell carcinoma support a genetic relationship between the two. The confinement of p53 staining to immature cell nuclei is consistent with maturation-dependent degradation of mutant p53 protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20062014     DOI: 10.1038/modpathol.2009.179

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  23 in total

1.  CD274 (PD-L1), CDKN2A (p16), TP53, and EGFR immunohistochemical profile in primary, recurrent and metastatic vulvar cancer.

Authors:  Sofia Lérias; Susana Esteves; Fernanda Silva; Mário Cunha; Daniela Cochicho; Luís Martins; Ana Félix
Journal:  Mod Pathol       Date:  2019-12-16       Impact factor: 7.842

Review 2.  [Interdisciplinary S2k guidelines on the diagnosis and treatment of vaginal carcinoma and its precursors-recommendations on surgical pathology for histopathological workup, diagnostics, and reporting].

Authors:  Lars-Christian Horn; Anne Kathrin Höhn; Monika Hampl; Grit Mehlhorn; Markus Follmann; Hans-Georg Schnürch
Journal:  Pathologe       Date:  2021-02       Impact factor: 1.011

3.  HPV-negative penile squamous cell carcinoma: disruptive mutations in the TP53 gene are common.

Authors:  Karl Kashofer; Elke Winter; Iris Halbwedl; Andrea Thueringer; Marisa Kreiner; Stefan Sauer; Sigrid Regauer
Journal:  Mod Pathol       Date:  2017-04-07       Impact factor: 7.842

4.  Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva.

Authors:  Deyin Xing; Yuehua Liu; Hyeon Jin Park; Inji Baek; Hung Tran; Gloria Cheang; Jorge Novo; Jessica Dillon; Andres Matoso; Emily Farmer; Max A Cheng; Ya-Chea Tsai; Kara Lombardo; Michael G Conner; Russell Vang; Chien-Fu Hung; Tzyy-Choou Wu; Wei Song
Journal:  Hum Pathol       Date:  2019-08-19       Impact factor: 3.466

5.  Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes.

Authors:  Annsofi Sandberg; Gunnel Lindell; Brita Nordström Källström; Rui Mamede Branca; Kristina Gemzell Danielsson; Mats Dahlberg; Barbro Larson; Jenny Forshed; Janne Lehtiö
Journal:  Mol Cell Proteomics       Date:  2012-04-12       Impact factor: 5.911

Review 6.  Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?

Authors:  Yong Weon Yi; Kyu Sic You; Jeong-Soo Park; Seok-Geun Lee; Yeon-Sun Seong
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

7.  Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status.

Authors:  Tjalling Bosse; Lynn N Hoang; Basile Tessier-Cloutier; Kim E Kortekaas; Emily Thompson; Jennifer Pors; Julia Chen; Julie Ho; Leah M Prentice; Melissa K McConechy; Christine Chow; Lily Proctor; Jessica N McAlpine; David G Huntsman; C Blake Gilks
Journal:  Mod Pathol       Date:  2020-03-20       Impact factor: 7.842

Review 8.  Squamous precursor lesions of the vulva: current classification and diagnostic challenges.

Authors:  Lien N Hoang; Kay J Park; Robert A Soslow; Rajmohan Murali
Journal:  Pathology       Date:  2016-04-23       Impact factor: 5.306

Review 9.  Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer.

Authors:  Christopher P Crum; Michael Herfs; Gang Ning; Jonathan G Bijron; Brooke E Howitt; Cynthia A Jimenez; Suchanan Hanamornroongruang; Frank D McKeon; Wa Xian
Journal:  J Pathol       Date:  2013-12       Impact factor: 7.996

10.  Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome.

Authors:  Basile Tessier-Cloutier; Jennifer Pors; Emily Thompson; Julie Ho; Leah Prentice; Melissa McConechy; Rosalia Aguirre-Hernandez; Ruth Miller; Samuel Leung; Lily Proctor; Jessica N McAlpine; David G Huntsman; C Blake Gilks; Lynn N Hoang
Journal:  Mod Pathol       Date:  2020-08-13       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.